Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Is Microdosing Cannabis Effective for CRPS? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

Microdosing, taking very small amounts of cannabis, is gaining attention as a potential strategy for managing Complex Regional Pain Syndrome. For patients who want symptom relief without intense psychoactive effects, it offers a promising middle ground. But how does it work, and is it effective across both Type I vs Type II CRPS? 

CRPS, whether trauma-induced (Type I) or linked to confirmed nerve injury (Type II), involves erratic signalling from the nervous system. Microdosing aims to gently regulate that system, calming overactive pain receptors and reducing inflammation without sedation. 

Book Consultation for Medical Cannabis

Microdosing by CRPS Type 

Here’s how microdosing performs across Type I vs Type II CRPS: 

  • Type I (reflex sympathetic dystrophy) 
    Patients with this form often experience widespread swelling and sensitivity. Microdosing CBD-dominant products may help control inflammation and modulate stress responses with minimal interference in daily function. 
  • Type II (causalgia) 
    This type often brings sharp, burning neuropathic pain due to direct nerve damage. Low-dose THC or balanced CBD/THC formulas can desensitise nerve signals and provide relief while preserving clarity and mobility. 
  • Benefits of a gentler approach 
    Microdosing is ideal for patients sensitive to full doses or those managing long-term use. It can reduce side effects and extend treatment duration by keeping tolerance low. 
  • Track, refine, repeat 
    Like all cannabis treatments, microdosing requires attention to results. Logging your response helps refine timing, product type, and frequency for optimal effect. 

Whether you’re dealing with Type I vs Type II CRPS, microdosing may offer a measured, sustainable way to control symptoms, especially when other treatments feel too aggressive. 

Visit providers like LeafEase for expert help in building a microdosing plan tailored to your pain profile and lifestyle. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Complex Regional Pain Syndrome (CRPS). 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories